THUNDER GOD VINE

OTHER NAME(S):

Huang-T'eng Ken, Lei Gong Teng, Lei-Kung T'eng, Taso-Ho-Hua, Threewingnut, Tonnerre de la Vigne de Dieu, Tripterigium Wilfordii, Tripterygium wilfordii, Vigne du Tonnerre Divin, Yellow Vine.<br/><br/>

Overview

Overview Information

Thunder god vine is an herb. Its leaves and root are used to make medicine.

Thunder god vine is used for rheumatoid arthritis (RA), heavy menstrual flows, multiple sclerosis, and as a male contraceptive. It is also used for pockets of infection (abscesses), boils, fever, swelling (inflammation), systemic lupus erythematosus (SLE), HIV/AIDS, a skin condition called psoriasis, and a blood vessel disease called Behcet's disease.

Thunder god vine is sometimes applied to the skin for rheumatoid arthritis.

Thunder god vine has also been used non-medicinally as an insecticide against maggots or larvae, and as a rat and bird poison.

How does it work?

Thunder god vine might help rheumatoid arthritis (RA) by relieving swelling (inflammation) and by changing the way the immune system responds to the arthritis. Thunder god vine contains chemicals that might decrease male fertility by changing sperm.

Uses

Uses & Effectiveness?

Possibly Effective for

  • Rheumatoid arthritis (RA). Taking thunder god vine by mouth seems to relieve joint pain and swelling and improve physical function in people with RA. It also seems to improve the effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) when taken for RA symptoms. Taking thunder god vine extract by mouth along with methotrexate seems to be as effective as taking methotrexate alone for RA symptoms, but with fewer side effects. Applying a liquid preparation (tincture) of thunder god vine to the skin over affected joints seems to decrease joint tenderness, stiffness, and swelling. However, serious side effects may occur in people taking thunder god vine for RA symptoms, so talk with your healthcare provider before starting thunder god vine.

Insufficient Evidence for

  • Male contraception. Taking thunder god vine by mouth might be effective as a male contraceptive. Fertility returns about 6 weeks after men stop taking thunder god vine.
  • A kidney condition called nephrotic syndrome. Early research suggests thunder god vine may be effective for nephrotic syndrome in children.
  • Kidney transplant. Taking thunder god vine before a kidney transplant and for 5 years thereafter might prevent transplant rejection and improve survival in some people undergoing kidney transplantation. Other research suggests that taking thunder god vine along with cyclosporine and prednisone might improve the function and 1-2 year survival rate of the transplanted kidney compared to treatment with azathioprine, cyclosporine, and prednisone.
  • Systemic lupus erythematosus (SLE). Some early research shows that thunder god vine may be effective for kidney problems (nephritis) associated with SLE. However, taking thunder god vine along with prednisone does not appear to improve symptoms better than prednisone alone.
  • HIV/AIDS.
  • Menstrual pain.
  • Multiple sclerosis (MS).
  • Pockets of infection (abscesses).
  • Boils.
  • Other conditions.
More evidence is needed to rate the effectiveness of thunder god vine for these uses.

Side Effects

Side Effects & Safety

Thunder god vine is POSSIBLY SAFE for most people when taken by mouth or applied to the skin in appropriate amounts. It can cause many side effects such as stomach upset, skin reactions, missed menstrual periods, vomiting, diarrhea, and kidney problems.

Special Precautions & Warnings:

Pregnancy and breast-feeding: Thunder god vine is LIKELY UNSAFE to take by mouth during pregnancy. It might cause birth defects.

Not enough is known about the safety of using thunder god vine during breast-feeding. Stay on the safe side and avoid use.

Weakened immune system: Large doses of thunder god vine might weaken the immune system. If you already have a weakened immune system due to HIV/AIDS, medications used to reduce the chance of organ transplant rejection, or for other reasons, avoid using thunder god vine. It might decrease your body’s ability to fight off infection.

Weakened bones (osteoporosis): Thunder god vine can reduce bone strength. If you have osteoporosis or are likely to develop it, don’t use thunder god vine.

Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Medications that decrease the immune system (Immunosuppressants) interacts with THUNDER GOD VINE

    Large doses of thunder god vine might decrease the immune system. Taking thunder god vine along with other medications that decrease the immune system might decrease the immune system too much. Avoid taking thunder god vine with medications that decrease the immune system.<br /> Some medications that decrease the immune system include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), corticosteroids (glucocorticoids), and others.

Dosing

Dosing

The following doses have been studied in scientific research:

BY MOUTH:

  • For rheumatoid arthritis (RA): 180-570 mg of thunder god vine extract per day for up to 20 weeks.
  • For kidney problems (nephrotic syndrome) in children: 1 mg per kg of body weight daily for up to 20 weeks.
APPLIED TO THE SKIN:
  • For rheumatoid arthritis (RA): a tincture of thunder god vine applied over affected joints five to six times daily.

View References

REFERENCES:

  • Ao, J. H., Li, Y. T., and Xiao, X. R. [Clinical study on the use of multiglycosides of Tripterygium wilfordii after cadaveric kidney transplantation]. Zhonghua Wai Ke.Za Zhi. 1994;32(3):175-177. View abstract.
  • Canter, P. H., Lee, H. S., and Ernst, E. A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis. Phytomedicine 2006;13(5):371-377. View abstract.
  • Carter, B. Z., Mak, D. H., Schober, W. D., McQueen, T., Harris, D., Estrov, Z., Evans, R. L., and Andreeff, M. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 7-15-2006;108(2):630-637. View abstract.
  • Chan, M. A., Kohlmeier, J. E., Branden, M., Jung, M., and Benedict, S. H. Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. Phytother.Res. 1999;13(6):464-467. View abstract.
  • Chang, D. M., Chang, W. Y., Kuo, S. Y., and Chang, M. L. The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol. 1997;24(3):436-441. View abstract.
  • Chang, M. L., Yang, L. L., Chang, D. M., Kuo, S. Y., and Chu, S. J. [The influence of Chinese traditional medicine on the production and activity of interleukin 1 (IL-1)]. Zhonghua Min Guo.Wei Sheng Wu Ji.Mian.Yi.Xue.Za Zhi. 1993;26(1):15-24. View abstract.
  • Chang, W. T., Kang, J. J., Lee, K. Y., Wei, K., Anderson, E., Gotmare, S., Ross, J. A., and Rosen, G. D. Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway. J Biol.Chem. 1-19-2001;276(3):2221-2227. View abstract.
  • Chen, K., Shi, Q., Fujioka, T., Nakano, T., Hu, C. Q., Jin, J. Q., Kilkuskie, R. E., and Lee, K. H. Anti-AIDS agents--XIX. Neotripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: isolation and structural elucidation. Bioorg.Med Chem. 1995;3(10):1345-1348. View abstract.
  • Choi, Y. J., Kim, T. G., Kim, Y. H., Lee, S. H., Kwon, Y. K., Suh, S. I., Park, J. W., and Kwon, T. K. Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells. Biochem.Pharmacol. 7-15-2003;66(2):273-280. View abstract.
  • Dong, Y. [The suppressive effect of Tripterygium wilfordii hook F on the IL-2 autocrine loop of human T cells]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1993;15(3):193-196. View abstract.
  • Du, X., Zhang, H., and Fu, X. [Clinical study on tripterygium wilfordii complex ester tablet in treating rheumatoid arthritis]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1998;18(2):88-91. View abstract.
  • Duan, H., Takaishi, Y., Momota, H., Ohmoto, Y., Taki, T., Jia, Y., and Li, D. Immunosuppressive diterpenoids from Tripterygium wilfordii. J Nat.Prod. 1999;62(11):1522-1525. View abstract.
  • Duan, H., Takaishi, Y., Momota, H., Ohmoto, Y., Taki, T., Jia, Y., and Li, D. Immunosuppressive sesquiterpene alkaloids from Tripterygium wilfordii. J Nat.Prod. 2001;64(5):582-587. View abstract.
  • Frese, S., Pirnia, F., Miescher, D., Krajewski, S., Borner, M. M., Reed, J. C., and Schmid, R. A. PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. Oncogene 8-21-2003;22(35):5427-5435. View abstract.
  • Gao, Y. and Chen, D. [Clinical study on effect of Tripterygium wilfordii Hook. f. on uterin leiomyoma]. Zhonghua Fu Chan Ke.Za Zhi. 2000;35(7):430-432. View abstract.
  • Gu, C. X. [Cause of amenorrhea after treatment with tripterygium wilfordii F]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1989;11(2):151-153. View abstract.
  • Guo, W., Ma, L., and Tao, X. [In vitro inhibitive effects of Tripterygium wilforii on NO production, iNOS activity, and iNOS-mRNA expression in chondrocyrtes of patients with rheumatoid arthritis]. Zhonghua Yi.Xue.Za Zhi. 9-10-2001;81(17):1035-1037. View abstract.
  • Guo, Y., Yu, M., Jiang, Y., Song, Q., and Dong, Y. [Effect of Tripterygium Wilfordii Hook T4 monomer on proliferation and interleukin-6 production of synovial fibroblasts of patients with rheumatoid arthritis]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 2000;22(2):190-192. View abstract.
  • Hayashi, K., Hayashi, T., Ujita, K., and Takaishi, Y. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2. J Antimicrob.Chemother. 1996;37(4):759-768. View abstract.
  • Ho, L. J., Chang, D. M., Chang, M. L., Kuo, S. Y., and Lai, J. H. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J Rheumatol. 1999;26(1):14-24. View abstract.
  • Hu, J., Li, C. W., Zhang, X., Pi, S. H., Zhao, J. S., Chen, X. Y., and Liu, Y. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children]. Zhonghua Er.Ke.Za Zhi. 2003;41(6):430-434. View abstract.
  • Hu, K. B., Liu, Z. H., Liu, D., and Li, L. S. Inhibition of vascular endothelial growth factor expression and production by triptolide. Planta Med 2002;68(4):368-369. View abstract.
  • Huang, H. [Clinical analysis of 31 cases of poisoning with Tripterygium wilfordii Hook. f., a Chinese traditional herb medicine]. Zhonghua Nei Ke.Za Zhi. 1982;21(6):363-365. View abstract.
  • Huang, H. H., Yen, D. H., Wu, M. L., Deng, J. F., Huang, C. I., and Lee, C. H. Acute Erycibe henryi Prain ("Ting Kung Teng") poisoning. Clin.Toxicol.(Phila) 2006;44(1):71-75. View abstract.
  • Ji, S. M., Wang, Q. W., Chen, J. S., Sha, G. Z., Liu, Z. H., and Li, L. S. Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China. Transplant.Proc. 2006;38(5):1274-1279. View abstract.
  • Jia, T. H., Sun, H. C., Wang, X. X., Xiu, H. M., Ding, W. D., Hao, X. D., Wu, L., Wang, G. X., and Lei, J. Z. Ultrastructural observation on macrophage-lymphocyte interactions in semen from Tripterygium wilfordii Hook.f. takers. Chin Med J (Engl.) 1994;107(12):892-896. View abstract.
  • Jiang, M. [The effect of glycoside Tripterygium wilfordii Hook F on the immune regulatory function of T lymphocyte]. Zhonghua Yi.Xue.Za Zhi. 1992;72(8):473-10. View abstract.
  • Jiang, X. H., Wong, B. C., Lin, M. C., Zhu, G. H., Kung, H. F., Jiang, S. H., Yang, D., and Lam, S. K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 11-29-2001;20(55):8009-8018. View abstract.
  • Kao, N. L., Richmond, G. W., and Moy, J. N. Resolution of severe lupus nephritis associated with Tripterygium wilfordii hook F ingestion. Arthritis Rheum. 1993;36(12):1751-1752. View abstract.
  • Kiviharju, T. M., Lecane, P. S., Sellers, R. G., and Peehl, D. M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin.Cancer Res. 2002;8(8):2666-2674. View abstract.
  • Krakauer, T., Chen, X., Howard, O. M., and Young, H. A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol.Immunotoxicol. 2005;27(1):53-66. View abstract.
  • Kumar, D. S., Lau, C. S., Wan, J. M., Yang, D., and Hyde, K. D. Immunomodulatory compounds from Pestalotiopsis leucothes, an endophytic fungus from Tripterygium wilfordii. Life Sci 11-26-2005;78(2):147-156. View abstract.
  • Kusunoki, N., Yamazaki, R., Kitasato, H., Beppu, M., Aoki, H., and Kawai, S. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC.Pharmacol. 2-17-2004;4:2. View abstract.
  • Lai, J. H., Ho, L. J., Lu, K. C., Chang, D. M., Shaio, M. F., and Han, S. H. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J Immunol. 6-1-2001;166(11):6914-6924. View abstract.
  • Lee, K. Y., Park, J. S., Jee, Y. K., and Rosen, G. D. Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-kappaB activation. Exp.Mol.Med 12-31-2002;34(6):462-468. View abstract.
  • Leishi, L. [Clinical study of Tripterygium wilfordii Hook in treating glomerulonephritis (author's transl)]. Zhonghua Nei Ke.Za Zhi. 1981;20(4):216-220. View abstract.
  • Li, L. F. Treatment of pyoderma gangrenosum with oral Tripterygium wilfordii multiglycoside. J Dermatol. 2000;27(7):478-481. View abstract.
  • Li, L. S. [Clinical and experimental studies on the effect of Tripterygium wilfordii Hook in the treatment of nephritis]. Zhonghua Yi.Xue.Za Zhi. 1982;62(10):581-585. View abstract.
  • Li, R. L., Liu, P. L., and Wu, X. C. [Clinical and experimental study on sustained release tablet of Tripterygium wilfordii in treating rheumatoid arthritis]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1996;16(1):10-13. View abstract.
  • Li, X. W. and Weir, M. R. Radix Tripterygium wilfordii--a Chinese herbal medicine with potent immunosuppressive properties. Transplantation 1990;50(1):82-86. View abstract.
  • Li, X. Y. Immunomodulating Chinese herbal medicines. Mem.Inst.Oswaldo Cruz 1991;86 Suppl 2:159-164. View abstract.
  • Liacini, A., Sylvester, J., and Zafarullah, M. Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes. Biochem.Biophys.Res.Commun. 2-4-2005;327(1):320-327. View abstract.
  • Lin, K. X., Wang, C. Z., and Qian, G. S. [Effect of Tripterygium wilfordii on Th1, Th2 cytokines production in asthma patients]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2001;21(1):22-24. View abstract.
  • Lin, N., Sato, T., and Ito, A. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Arthritis Rheum. 2001;44(9):2193-2200. View abstract.
  • Lin, S., Li, Y. C., Sakurai, N., Lin, J. F., and Jin, J. J. [Study of sesquiterpene alkaloids from Tripterygium wilfordii Hook.f.]. Yao Xue.Xue.Bao. 2001;36(2):116-119. View abstract.
  • Liu, J., Wu, Q. L., Feng, Y. H., Wang, Y. F., Li, X. Y., and Zuo, J. P. Triptolide suppresses CD80 and CD86 expressions and IL-12 production in THP-1 cells. Acta Pharmacol.Sin. 2005;26(2):223-227. View abstract.
  • Lou, Y. J. and Jin, J. Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk.Lymphoma 2004;45(2):373-376. View abstract.
  • Lu, Y., Fukuda, K., Nakamura, Y., Kimura, K., Kumagai, N., and Nishida, T. Inhibitory effect of triptolide on chemokine expression induced by proinflammatory cytokines in human corneal fibroblasts. Invest Ophthalmol.Vis.Sci 2005;46(7):2346-2352. View abstract.
  • Maekawa, K., Yoshikawa, N., Du, J., Nishida, S., Kitasato, H., Okamoto, K., Tanaka, H., Mizushima, Y., and Kawai, S. The molecular mechanism of inhibition of interleukin-1beta-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract. Inflamm.Res. 1999;48(11):575-581. View abstract.
  • Miyata, Y., Sato, T., and Ito, A. Triptolide, a diterpenoid triepoxide, induces antitumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells. Biochem.Biophys.Res.Commun. 11-4-2005;336(4):1081-1086. View abstract.
  • Ning, L., Qu, G., Ye, M., Guo, H., Bi, K., and Guo, D. Cytotoxic biotransformed products from triptonide by Aspergillus niger. Planta Med 2003;69(9):804-808. View abstract.
  • Pan, Y. R., Zhu, C. Y., Li, P., Wei, M., and Xu, D. H. Effect of Tripterygium wilfordii on nephritis of anaphylactoid purpura. Proc.Chin Acad.Med Sci Peking.Union Med Coll. 1987;2(1):45-47. View abstract.
  • Pan, Y. R., Zhu, C. Y., Wei, M., and Xu, B. M. [Tripterygium wilfordii in the treatment of the nephritis of anaphylactoid purpura]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1987;9(6):463-465. View abstract.
  • Panichakul, T., Intachote, P., Wongkajorsilp, A., Sripa, B., and Sirisinha, S. Triptolide sensitizes resistant cholangiocarcinoma cells to TRAIL-induced apoptosis. Anticancer Res. 2006;26(1A):259-265. View abstract.
  • Peng, D., Liu, Q., Zhao, Z., Huang, W., and Qiu, J. [An observation of the percutaneous absorption of total alkaloids and terpenoid lactones of Tripterygium wilfordii]. Zhong.Yao Cai. 1997;20(10):524-527. View abstract.
  • Pyatt, D. W., Yang, Y., Mehos, B., Le, A., Stillman, W., and Irons, R. D. Hematotoxicity of the chinese herbal medicine Tripterygium wilfordii hook f in CD34-positive human bone marrow cells. Mol.Pharmacol. 2000;57(3):512-518. View abstract.
  • Qin, W. Z., Zhu, G. D., Yang, S. M., Han, K. Y., and Wang, J. Clinical observations on Tripterygium wilfordii in treatment of 26 cases of discoid lupus erythematosus. J Tradit.Chin Med 1983;3(2):131-132. View abstract.
  • Ramgolam, V., Ang, S. G., Lai, Y. H., Loh, C. S., and Yap, H. K. Traditional Chinese medicines as immunosuppressive agents. Ann.Acad.Med Singapore 2000;29(1):11-16. View abstract.
  • Ren, Y., Xiong, L., and Wu, J. R. Induction of mitochondrion-mediated apoptosis of CHO cells by tripchlorolide. Cell Res. 2003;13(4):295-300. View abstract.
  • Setty, A. R. and Sigal, L. H. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin.Arthritis Rheum 2005;34(6):773-784. View abstract.
  • Shamon, L. A., Pezzuto, J. M., Graves, J. M., Mehta, R. R., Wangcharoentrakul, S., Sangsuwan, R., Chaichana, S., Tuchinda, P., Cleason, P., and Reutrakul, V. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 1-15-1997;112(1):113-117. View abstract.
  • Sharma, M., Li, J. Z., Sharma, R., Artero, M., Ge, X., McCarthy, E. T., Wang, H. Y., and Savin, V. Inhibitory effect of Tripterygium wilfordii multiglycoside on increased glomerular albumin permeability in vitro. Nephrol.Dial.Transplant. 1997;12(10):2064-2068. View abstract.
  • Siva Sundara, Kumar D., Cheung, H. Y., Lau, C. S., Chen, F., and Hyde, K. D. In vitro studies of endophytic fungi from Tripterygium wilfordii with anti-proliferative activity on human peripheral blood mononuclear cells. J Ethnopharmacol. 2004;94(2-3):295-300. View abstract.
  • Su, D., Song, Y., and Li, R. [Comparative clinical study of rheumatoid arthritis treated by triptolide and an ethyl acetate extract of Tripterygium wilfordii]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1990;10(3):144-6, 131. View abstract.
  • Sylvester, J., Liacini, A., Li, W. Q., Dehnade, F., and Zafarullah, M. Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities. Mol.Pharmacol. 2001;59(5):1196-1205. View abstract.
  • Takaishi, Y., Ujita, K., Nakano, K., and Tomimatsu, T. Structural elucidation of triptofordins F-1, F-2, F-3, and F-4, new sesquiterpenes polyesters from Tripterygium wilfordii HOOK fil. var. regelii MAKINO. Chem.Pharm.Bull.(Tokyo) 1988;36(11):4275-4283. View abstract.
  • Takaishi, Y., Ujita, K., Tokuda, H., Nishino, H., Iwashima, A., and Fujita, T. Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation. Cancer Lett. 7-31-1992;65(1):19-26. View abstract.
  • Tao, X. L. [Mechanism of treating rheumatoid arthritis with Tripterygium wilfordii hook. II. Effect on PGE2 secretion]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1989;11(1):36-40. View abstract.
  • Tao, X. L., Dong, Y., and Zhang, N. Z. [A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis]. Zhonghua Nei Ke.Za Zhi. 1987;26(7):399-5. View abstract.
  • Tao, X., Cai, J. J., and Lipsky, P. E. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F. J Pharmacol.Exp.Ther 1995;272(3):1305-1312. View abstract.
  • Tao, X., Davis, L. S., Hashimoto, K., and Lipsky, P. E. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. J Pharmacol.Exp.Ther 1996;276(1):316-325. View abstract.
  • Tao, X., Schulze-Koops, H., Ma, L., Cai, J., Mao, Y., and Lipsky, P. E. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 1998;41(1):130-138. View abstract.
  • Tao, X., Sun, Y., and Zhang, N. [Treatment of rheumatoid arthritis with low doses of multi-glycosides of Tripterygium wilfordii]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1990;10(5):289-2. View abstract.
  • Ushiro, S., Ono, M., Nakayama, J., Fujiwara, T., Komatsu, Y., Sugimachi, K., and Kuwano, M. New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization. Int J Cancer 8-7-1997;72(4):657-663. View abstract.
  • Wan, C. K., Wang, C., Cheung, H. Y., Yang, M., and Fong, W. F. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells. Cancer Lett. 9-8-2006;241(1):31-41. View abstract.
  • Wang, B. X. and Yuan, Z. Z. [A tablet of Tripterygium wilfordii in treating lupus erythematosus]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1989;9(7):407-8, 389. View abstract.
  • Wang, J., Wang, Y. T., Shao, J. Q., Wang, X., and Du, H. [Immunosuppressive therapies in patients with Graves' ophthalmopathy]. Zhonghua Nei Ke.Za Zhi. 2004;43(2):125-127. View abstract.
  • Wang, S. J., Yao, K., Xie, F. D., and Ji, X. H. Effects of Tripterygium wilfordii saponins and interleukin-10 on dendritic cells from human peripheral blood. Acta Pharmacol.Sin. 2001;22(8):721-724. View abstract.
  • Wang, X., Matta, R., Shen, G., Nelin, L. D., Pei, D., and Liu, Y. Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J Mol.Med 2006;84(5):405-415. View abstract.
  • Wei, Y. S. and Adachi, I. Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines. Zhongguo Yao Li Xue.Bao. 1991;12(5):406-410. View abstract.
  • Weng, M. W., Qiu, B. S., and Kang, K. F. An analysis of 24 patients with IgA deposition at the BMZ. J Dermatol. 1993;20(5):276-278. View abstract.
  • Wu, F., Zhang, Z., Ye, W., and Qian, X. [Comparative study on the effect of gossypol and T7 on human spermatozoa ATPase activity]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1998;20(4):267-270. View abstract.
  • Wu, Y. J., Lao, Z. Y., and Zhang, Z. L. [Clinical observation on small doses Tripterygium wilfordii polyglycoside combined with methotrexate in treating rheumatoid arthritis]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2001;21(12):895-896. View abstract.
  • Yan, S. X. and Wang, Y. Inhibitory effects of Triptolide on interferon-gamma-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy. Clin.Experiment.Ophthalmol. 2006;34(3):265-271. View abstract.
  • Yang, H., Chen, D., Cui, Q. C., Yuan, X., and Dou, Q. P. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 5-1-2006;66(9):4758-4765. View abstract.
  • Yang, J. H., Luo, S. D., Wang, Y. S., Zhao, J. F., Zhang, H. B., and Li, L. Triterpenes from Tripterygium wilfordii Hook. J Asian Nat.Prod.Res. 2006;8(5):425-429. View abstract.
  • Yang, S., Chen, J., Guo, Z., Xu, X. M., Wang, L., Pei, X. F., Yang, J., Underhill, C. B., and Zhang, L. Triptolide inhibits the growth and metastasis of solid tumors. Mol.Cancer Ther 2003;2(1):65-72. View abstract.
  • Yang, Y., Liu, Z., Tolosa, E., Yang, J., and Li, L. Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology 1998;40(2):139-149. View abstract.
  • Yao, J., Zhang, L., Zhao, X., Hu, L., and Jiang, Z. Simultaneous determination of triptolide, wilforlide A and triptonide in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Biol.Pharm.Bull. 2006;29(7):1483-1486. View abstract.
  • Yao, Q. P. and Zhang, N. Z. [Effects of tripchlorolide (T4) of Tripterygium wilfordii hook on the production of prostaglandin E2 by synovial cells of rheumatoid arthritis]. Yao Xue.Xue.Bao. 1994;29(10):790-792. View abstract.
  • Yao, Q., Zeng, Z., and Zhang, N. [Effect of tripchlorolide (T4) of Tripterygium wilfordii Hook on the production of endothelin-1 by endothelial cells of human umbilical vein]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1995;17(3):228-229. View abstract.
  • Ye, W. H. [Mechanism of treating rheumatoid arthritis with polyglycosides of Tripterygium wilfordii Hook (T II). III. Study on inhibitory effect of T II on in vitro Ig secreted by peripheral blood mononuclear cells from normal controls and RA patients]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1990;12(3):217-222. View abstract.
  • Yin, Z. and Chu, W. The suspension culture of Tripterygium wilfordii. Chin J Biotechnol. 1992;8(1):67-71. View abstract.
  • Yu, H. L. [Treatment of purpuric nephritis in children with Tripterygium wilfordii and radix Salviae miltiorrhizae]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1992;12(6):343-4, 324. View abstract.
  • Yu, K. T., Nuss, G., Boyce, R., Jariwala, N., Owens, G., Pennetti, A., Chan, W., Zhang, D. C., Chang, M. N., and Zilberstein, A. Inhibition of IL-1 release from human monocytes and suppression of streptococcal cell wall and adjuvant-induced arthritis in rats by an extract of Tripterygium wilfordii Hook. Gen.Pharmacol. 1994;25(6):1115-1122. View abstract.
  • Zeng, X. and Zhang, N. [The effects of a single active ingredient (T4) of Tripterygium Wilfordii Hook on the production of tumor necrosis factor by the peripheral blood mononuclear cells and synovium cells of rheumatoid arthritis patients]. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 1996;18(2):138-142. View abstract.
  • Zeng, X. J. and Zhang, N. Z. [Effects of tripchlorolide (T4) of Tripterygium Wilfordii Hook on the production of immunoglobulins by peripheral blood mononuclear cells and by synovial cells of rheumatoid arthritis patients in vitro]. Yao Xue.Xue.Bao. 1997;32(3):171-173. View abstract.
  • Zhang, D. H., Marconi, A., Xu, L. M., Yang, C. X., Sun, G. W., Feng, X. L., Ling, C. Q., Qin, W. Z., Uzan, G., and d'Alessio, P. Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. J Leukoc.Biol. 2006;80(2):309-319. View abstract.
  • Zhang, W. Z. and Wang, S. H. [Remote effect of Tripterygium wilfordii and chlorambucil on the function of sex glands of child with nephropathy]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1996;16(2):113-114. View abstract.
  • Zheng, D. H. [Clinical analysis of 84 cases of glomerulonephritis treated with Tripterygium wilfordii]. Zhong.Xi.Yi.Jie.He.Za Zhi. 1984;4(10):604-6, 579. View abstract.
  • Zhou, B. N. Some progress on the chemistry of natural bioactive terpenoids from Chinese medicinal plants. Mem.Inst.Oswaldo Cruz 1991;86 Suppl 2:219-226. View abstract.
  • Zhou, J. H., Huang, A. X., and Liu, T. L. [Clinical study on treatment of childhood Henoch-Schonlein purpura nephritis with colquhounia root tablet]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2004;24(5):418-421. View abstract.
  • Zhou, X., Zhou, Z., Jin, M., Wang, H., Wu, M., Song, Y., and Cheng, H. Clinical study of qingluo tongbi granules in treating 63 patients with rheumatoid arthritis of the type of yin-deficiency and heat in collaterals. J Tradit.Chin Med 2004;24(2):83-87. View abstract.
  • Zhou, Y. X., Huang, Y. L., Xu, Q. N., Ye, M., Sun, C. F., and Zhou, D. [Several monomes from Tripterygium wilfordii inhibit proliferation of glioma cells in vitro]. Ai.Zheng. 2002;21(10):1106-1108. View abstract.
  • Zhou, Z., He, S., and Liang, Y. [Effects of tripterygium wilfordii polyglyco - sidium on intraocular inflammatory reaction after intraocular lens implantation]. Zhonghua Yan.Ke.Za Zhi. 1998;34(5):332-335. View abstract.
  • Zhu, K. J., Shen, Q. Y., Cheng, H., Mao, X. H., Lao, L. M., and Hao, G. L. Triptolide affects the differentiation, maturation and function of human dendritic cells. Int Immunopharmacol. 2005;5(9):1415-1426. View abstract.
  • Chang DM, Kuo SY, Lai JH, Chang ML. Effects of anti-rheumatic herbal medicines on cellular adhesion molecules. Ann Rheum Dis 1999;58:366-71. View abstract.
  • Chen K, Shi Q, Kashiwada Y, et al. Anti-AIDS agents, 6. Salaspermic acid, an anti-HIV principle from Tripterygium wilfordii, and the structure-activity correlation with its related compounds. J Nat Prod 1992;55:340-6. View abstract.
  • Chen K, Shi QA, Fujioka T, et al. Anti-AIDS agents, 4. Tripterifordin, a novel anti-HIV principle from Tripterygium wilfordii: isolation and structural elucidation. J Nat Prod 1992;55:88-92. View abstract.
  • Chou CT, Chang SC. The inhibitory effect of common traditional anti-rheumatic herb formulas on prostaglandin E and interleukin 2 in vitro: a comparative study with Tripterygium wilfordii. J Ethnopharmacol 1998;62:167-71. View abstract.
  • Chou WC, Wu CC, Yang PC, Lee YT. Hypovolemic shock and mortality after ingestion of Tripterygium wilfordii hook F: a case report. Int J Cardiol 1995;49:173-7. View abstract.
  • Cibere J, Deng Z, Lin Y, et al. A Randomized Double Blind, Placebo Controlled Trial of Topical Tripterygium wilfordii in Rheumatoid Arthritis: Reanalysis Using Logistic Regression Analysis. J Rheumatol 2003;30:465-7.. View abstract.
  • ClinicalTrials.gov. Treating Rheumatoid Arthritis with Tripterygium Wilfordi Hook F or Sulfasalazine. Available at: http://www.clinicaltrials.gov/ct/show/NCT00062465?order=1.
  • Duan H, Takaishi Y, Momota H, et al. Triterpenoids from Tripterygium wilfordii. Phytochemistry 2000;53:805-10. View abstract.
  • Hemila H. Does vitamin C alleviate the symptoms of the common cold?- a review of current evidence. Scand J Infect Dis 1994;26:1-6. View abstract.
  • Hemila H. Vitamin C, the placebo effect, and the common cold: a case study of how preconceptions influence the analysis of results. J Clin Epidemiol 1996;49:1079-84. View abstract.
  • Huang L, Feng S, Wang H. Decreased bone mineral density in female patients with systemic lupus erythematosus after long-term administration of Tripterygium Wilfordii Hook. F. Chin Med J 2000;113:159-61.. View abstract.
  • Jiang L, Zhao N, Ni L. Retrospective study of adverse events in patients with rheumatoid arthritis treated with second-line drugs. Zhonghua Liu Xing Bing Xue Za Zhi 2002;23:213-7.. View abstract.
  • Jiang X. Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome. Pediatr Nephrol 1994;8:343-4.. View abstract.
  • Kao NL, Richmond GW, Moy JN. Resolution of severe lupus nephritis associated with Tripterygium wilfordii hook F ingestion. Arthritis Rheum 1993;36:1751-2.
  • Li RW, David Lin G, Myers SP, Leach DN. Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 2003;85:61-7. View abstract.
  • Lipsky PE, Tao XL. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 1997;26:713-23.. View abstract.
  • Lue Y, Sinha Hikim AP, Wang C, et al. Triptolide: a potential male contraceptive. J Androl 1998;19:479-86.. View abstract.
  • Luk JM, Lai W, Tam P, Koo MW. Suppression of cytokine production and cell adhesion molecule expression in human monocytic cell line THP-1 by Tripterygium wilfordii polysaccharide moiety. Life Sci 2000;67:155-63. View abstract.
  • Qian SZ, Hu YZ, Wang SM, et al. Effects of Tripterygium hypoglaucum (Levl.) Hutch on male fertility. Adv Contracept 1988;4:307-10.. View abstract.
  • Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 2003;4:1-18.. View abstract.
  • Shi YL, Bai JP, Wang WP. Ion-channels in human sperm membrane and contraceptive mechanisms of male antifertility compounds derived from Chinese traditional medicine. Acta Pharmacol Sin 2003;24:22-30.. View abstract.
  • Takei A, Nagashima G, Suzuki R, et al. Meningoencephalocele associated with Tripterygium wilfordii treatment. Pediatr Neurosurg 1997;27:45-8. View abstract.
  • Tao X, Cush JJ, Garret M, Lipsky PE. A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 2001;28:2160-7.. View abstract.
  • Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-81. View abstract.
  • Tao X, Younger J, Fan FZ, et al. Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum 2002;46:1735-43.. View abstract.
  • Tao XL, Sun Y, Dong Y, et al. A prospective, controlled, double-blind, cross-over study of tripterygium wilfodii hook F in treatment of rheumatoid arthritis. Chin Med J 1989;102:327-32. View abstract.
  • Zhen QS, Ye X, Wei ZJ. Recent progress in research on Tripterygium: a male antifertility plant. Contraception 1995;51:121-9.. View abstract.

More Resources for THUNDER GOD VINE

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version. © Therapeutic Research Faculty 2009.